<DOC>
	<DOCNO>NCT01724307</DOCNO>
	<brief_summary>The purpose study evaluate stimulate nerve involve airway constriction , undergoing procedure know cause asthma exacerbation , decrease level asthma attack experience .</brief_summary>
	<brief_title>Stimulation Cervical Sympathetic Ganglion Treatment Asthma</brief_title>
	<detailed_description>Asthma chronic inflammatory disorder airway characterize shortness breath , wheeze , cough , fatigue . Some people suffer sudden worsening asthma symptom despite treated medication . When people asthma attack muscle tissue airway contract cause airway narrow decrease ability person breathe . Neurological pacemaker FDA approve device stimulate nerve body use treatment many disorder Parkinson 's , epilepsy , chronic pain urinary incontinence . Recent animal study show stimulating ( activate nerve ) carotid sheath area ( locate neck ) cause rapid relaxation muscle contract asthma attack . This approach also successfully used patient emergency room come severe asthma attack .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . All patient age 1870 year age suffer mildtomoderate asthma either : 1. bronchial hyperresponsiveness MCT 2. bronchial hyperresponsiveness EVH test 2 . All patient document evidence positive MCT EVH test within 36 month Visit 1 3 . Are capable read understanding questionnaire provide write informed consent . 4 . Are willing able adhere study visit schedule protocolspecified procedure . 1 . NonEnglish speaking . 2 . Subjects experience exacerbation asthma within 6 week Visit 1 3 . Subjects force expiratory volume ( FEV1 ) ≤ 60 % predict , spirometry 4 . Subjects medication : 1 . Subjects allergic methacholine parasympathomimetic agent 2 . Subjects investigational drug participate interventional research trial ( ) , 30 day prior enrollment duration study 3 . Subjects currently βadrenergic blocker , cholinesterase inhibitor 4 . Prior administer MCT/ EVH test : ) use shortacting bronchodilator ( within 6hrs . ) ii ) use longacting bronchodilator ( within 36hrs . ) iii ) use inhale corticosteroids/ leukotriene modifier ( within 72hrs . ) iv ) exercise ( within 4hrs . ) 5 . Subject smoking : last 6 month smoke history &gt; 10 packyears 6 . Subjects experience febrile illness within 3 week Visit 1 7 . Subjects history active poorly control epilepsy , cardiovascular disease ( esp . bradycardia ) , vagotonia , peptic ulcer disease , thyroid disease , urinary tract obstruction chronic ailment would interfere current study 8 . Subjects pregnant refuse medically acceptable contraception study period 9 . Subjects history &gt; 3 stellate ganglion block procedure 10 . Subjects undergone surgical procedure involve cervical spine 11 . Evidence coagulopathy abnormal INR , PT/ PTT platelet count 12 . Subjects allergic lidocaine ( Subject may still participate study agree procedure without use Lidoderm patch ) 13 . Subjects participate another interventional research trial 14 . Subjects condition compliance issue , investigator 's opinion might interfere participation current study 15 . Subjects unable unwilling provide write consent undergo require testing/ procedures/ physical exam answer questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>